[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Zoetis Earnings Preview: What to Expect

With a market cap of $31.2 billion, Zoetis Inc. (ZTS) is the world's leading animal health company, dedicated to advancing animal care through innovative medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. With nearly 75 years of scientific expertise and a presence in over 100 countries, Zoetis empowers veterinarians, livestock producers, and pet owners by pioneering solutions to predict, prevent, detect, and treat animal illness.

The Parsippany, New Jersey-based company is slated to announce its fiscal Q2 2026 results before the market opens on Thursday, Aug. 6. Ahead of the event, analysts expect Zoetis to report an adjusted EPS of $1.85, up 5.1% from ...

Fundamentals

See More
  • Market Capitalization, $K 31,245,062
  • Shares Outstanding, K 419,228
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,435 M
  • EBITDA $ 3,922 M
  • 60-Month Beta 0.75
  • Price/Sales 3.28
  • Price/Cash Flow 9.97
  • Price/Book 9.81

Options Overview Details

View History
  • Implied Volatility 47.55% (-1.67%)
  • Historical Volatility 29.93%
  • IV Percentile 98%
  • IV Rank 93.74%
  • IV High 49.22% on 07/14/26
  • IV Low 22.52% on 08/12/25
  • Expected Move (DTE 1) 1.40 (1.88%)
  • Put/Call Vol Ratio 1.32
  • Today's Volume 7,322
  • Volume Avg (30-Day) 4,845
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 160,638
  • Open Int (30-Day) 146,680
  • Expected Range 73.13 to 75.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.85
  • Number of Estimates 8
  • High Estimate $1.89
  • Low Estimate $1.77
  • Prior Year $1.76
  • Growth Rate Est. (year over year) +5.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.47 +4.28%
on 06/30/26
80.58 -7.51%
on 06/16/26
-5.42 (-6.78%)
since 06/15/26
3-Month
71.47 +4.28%
on 06/30/26
123.32 -39.56%
on 04/20/26
-46.23 (-38.28%)
since 04/15/26
52-Week
71.47 +4.28%
on 06/30/26
160.48 -53.56%
on 08/20/25
-78.33 (-51.24%)
since 07/15/25

Most Recent Stories

More News
Zoetis Earnings Preview: What to Expect

Zoetis is set to post its second-quarter results next month, and analysts project a single-digit earnings rise.

ABT : 89.27 (+0.35%)
XLV : 158.29 (unch)
$SPX : 7,572.40 (+0.38%)
ZTS : 74.53 (+0.62%)
Zoetis Deadline: ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK , July 15, 2026 /PRNewswire/ --

ZTS : 74.53 (+0.62%)
Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact KTMC

Did you buy ZTS securities between January 14, 2025, and May 6, 2026?

ZTS : 74.53 (+0.62%)
Levi & Korsinsky Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026 - ZTS

Notice to Pension Funds, Asset Managers, and Fiduciaries: Zoetis' Companion Animal Segment Collapse Allegedly Cost Institutional Portfolios Hundreds of Millions

ZTS : 74.53 (+0.62%)
Kaplan Fox & Kilsheimer LLP Alerts Zoetis Inc. (NYSE: ZTS) Investors to a Securities Class Action Deadline on July 27, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ZTS : 74.53 (+0.62%)
Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union

Up to 40% of dogs may have radiographic osteoarthritis - New long-acting monoclonal antibody therapy offers three months of osteoarthritis pain relief for dogs with a single injection

ZTS : 74.53 (+0.62%)
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm

NEW YORK , July 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).

ZTS : 74.53 (+0.62%)
Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities

Acquisition would strengthen Zoetis’ Global Diagnostics portfolio through teleradiology, imaging services, and workflow technology, advancing a more comprehensive end-to-end Virtual Reference Lab

ZTS : 74.53 (+0.62%)
Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTS

LOS ANGELES , July 13, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or "the Company") (NYSE: ZTS ) for violations of §§10(b)...

ZTS : 74.53 (+0.62%)
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , July 13, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or "the...

ZTS : 74.53 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 78.05
2nd Resistance Point 77.22
1st Resistance Point 75.88
Last Price 74.53
1st Support Level 73.71
2nd Support Level 72.88
3rd Support Level 71.54

See More

52-Week High 160.48
Fibonacci 61.8% 126.48
Fibonacci 50% 115.97
Fibonacci 38.2% 105.47
Last Price 74.53
52-Week Low 71.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.